Join
Live feed
·
PRReleasevia Quantisnow
Immatics N.V. logo

Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer

ByQuantisnow·Wall Street's wire, on your screen.
IMTX· Immatics N.V.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMTX (Immatics N.V.) and more on Quantisnow.